Akero Therapeutics, Inc.

Ensign Peak Advisors, Inc AKRO

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/13/2025

Shares

207,692

Value ($000)

9,861

Weight

0.0%

2019 Q4 - 2025 Q3 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/13/2025	9,861	0.0%	207,692	9/30/2025
2025 Q2	8/12/2025	10,054	0.0%	188,409	6/30/2025
2025 Q1	5/14/2025	6,276	0.0%	155,044	3/31/2025
2024 Q4	2/14/2025	4,313	0.0%	155,044	12/31/2024
2024 Q3	11/14/2024	4,448	0.0%	155,044	9/30/2024
2024 Q2	8/13/2024	5,572	0.0%	237,494	6/30/2024
2024 Q1	5/14/2024	5,874	0.0%	232,544	3/31/2024
2023 Q4	2/14/2024	5,447	0.0%	233,264	12/31/2023
2023 Q3	11/13/2023	11,766	0.0%	232,614	9/30/2023
2023 Q2	8/14/2023	8,293	0.0%	177,614	6/30/2023
2023 Q1	5/15/2023	6,717	0.0%	175,564	3/31/2023
2022 Q4	2/13/2023	8,947	0.0%	163,264	12/31/2022
2022 Q3	11/14/2022	5,790	0.0%	170,034	9/30/2022
2022 Q2	8/12/2022	676	0.0%	71,491	6/30/2022
2022 Q1	5/16/2022	359	0.0%	25,285	3/31/2022
2021 Q4	2/11/2022	535	0.0%	25,285	12/31/2021
2021 Q3	11/12/2021	565	0.0%	25,285	9/30/2021
2021 Q2	8/13/2021	628	0.0%	25,285	6/30/2021
2021 Q1	5/12/2021	733	0.0%	25,285	3/31/2021
2020 Q4	2/12/2021	652	0.0%	25,285	12/31/2020
2020 Q3	11/12/2020	595	0.0%	19,321	9/30/2020
2020 Q2	8/12/2020	678	0.0%	27,202	6/30/2020
2020 Q1	5/11/2020	324	0.0%	15,269	3/31/2020
2019 Q4	2/14/2020	529	0.0%	23,823	12/31/2019